Quantcast

Latest non-surgical treatment Stories

2014-05-21 08:28:42

NORWALK, Conn., May 21, 2014 /PRNewswire/ -- A newly published peer-reviewed study that examines Stretta(®) therapy, further confirms the long-term effectiveness of this non-surgical treatment for gastroesophageal reflux disease (GERD). The 8-year study published in Gastroenterology Research and Practice, entitled "Durability of Stretta Radiofrequency Treatment for GERD: Results of 8-Year Follow-Up" corroborates the findings of another recently published long-term study on Stretta...

2014-01-30 23:31:04

RB Spine Center has added Intervertebral Differential Dynamics (IDD) Therapy to its suite of non-surgical treatment options for chronic back and neck conditions. San Diego, CA (PRWEB) January 30, 2014 RB Spine Center, a pain management and rehabilitation center in San Diego, has announced the addition of Intervertebral Differential Dynamics (IDD) Therapy to its suite of non-surgical treatment options for chronic back and neck conditions. The facility has also added new members to its team...

2013-07-31 23:34:04

A pair of new studies indicate that most patients with rotator cuff injuries respond well to non-surgical treatment, and a key predictor of who benefits most from physical therapy may simply be who expects to. This is good news for those coping with rotator cuff injuries, the most common cause of shoulder pain and dysfunction in adults, according to Jeffrey Yormak, MD. Carmel, NY (PRWEB) July 31, 2013 A pair of new studies indicate that most patients with rotator cuff injuries respond...

2013-02-06 23:03:43

The Retina Group of New York (RGONY) with offices in Hicksville and Hauppauge, NY, has announced the availability of JETREA® (Ocriplasmin), the first non-surgical treatment for patients with symptomatic Vitreo-macular Adhesion (VMA) or Vitreo-macular Traction (VMT). Hicksville and Hauppauge, NY (PRWEB) February 06, 2013 The Retina Group of New York (RGONY) with offices in Hicksville and Hauppauge, NY, has announced the availability of JETREA® (Ocriplasmin), the first non-surgical...

2010-09-01 00:29:00

LEUVEN, Belgium, September 1, 2010 /PRNewswire-FirstCall/ -- - Data Presented at ASRS Confirm Previous Phase III Findings and Microplasmin's Potential to Transform the Treatment of Retinal Disorders ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer announces that its second Phase III trial evaluating microplasmin for the non-surgical treatment of...

2010-07-01 00:27:00

LEUVEN, Belgium, July 1, 2010 /PRNewswire-FirstCall/ -- ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that data from the second Phase III trial of microplasmin (TG-MV-007) for the non-surgical treatment of vitreomacular adhesion (VMA), are to be presented at the 28th Annual Meeting of the American Society of Retina Specialists (ASRS) and the 10th EURETINA Congress....

2010-06-07 00:28:00

LEUVEN, Belgium, June 7, 2010 /PRNewswire-FirstCall/ -- - Data Presented Show Microplasmin Cures Approximately 50% of Patients With Macular Hole ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that further data from the first successful Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) were presented at the...

2010-04-20 00:30:00

LEUVEN, Belgium, April 20, 2010 /PRNewswire-FirstCall/ -- - Highly Significant Trial Result (p=0.003) Demonstrates the Potential of Microplasmin in the Treatment of Retinal Disease ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its first Phase III trial with microplasmin for the non-surgical treatment of eye disease has met its...

2010-03-10 08:47:32

Results of new studies will help surgeons and patients together determine Approximately 21 million visits were made to physicians' offices due to back problems in 2006. While countless adults experience back pain and stiffness, many suffer from serious spine and back conditions "“including injury, herniated discs and the deterioration of the vertebrae. Three new studies presented at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) detail advances in back...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related